OliX PharmaceuticalsInc (226950) — Financial Flexibility Index
OliX PharmaceuticalsInc (226950) has a Financial Flexibility Index of -0.26x as of December 2025. Free cash flow of ₩-11.77 Billion (operating CF ₩-12.16 Billion minus capex ₩384.97 Million) represents 0% of total liabilities (₩45.29 Billion). Also explore net asset growth rate of OliX PharmaceuticalsInc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OliX PharmaceuticalsInc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for OliX PharmaceuticalsInc across 10 annual periods. Check 226950 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for OliX PharmaceuticalsInc (2016–2025)
Year-by-year free cash flow to debt coverage for OliX PharmaceuticalsInc. For the full company profile including market capitalisation, see OliX PharmaceuticalsInc (226950) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | ₩-14.04 Billion | ₩-15.90 Billion | ₩45.29 Billion | ▼ -18.6% |
| 2024 | -0.26x | ₩-13.97 Billion | ₩-28.04 Billion | ₩53.40 Billion | ▼ -13.4% |
| 2023 | -0.23x | ₩-12.10 Billion | ₩-21.17 Billion | ₩52.49 Billion | ▲ +45.9% |
| 2022 | -0.43x | ₩-28.45 Billion | ₩-30.68 Billion | ₩66.74 Billion | ▼ -63.5% |
| 2021 | -0.26x | ₩-17.76 Billion | ₩-19.05 Billion | ₩68.15 Billion | ▼ -191.9% |
| 2020 | -0.09x | ₩-2.97 Billion | ₩-3.76 Billion | ₩33.29 Billion | ▲ +96.9% |
| 2019 | -2.85x | ₩-9.73 Billion | ₩-10.73 Billion | ₩3.41 Billion | ▲ +74.6% |
| 2018 | -11.24x | ₩-7.86 Billion | ₩-8.36 Billion | ₩698.94 Million | ▼ -845.8% |
| 2017 | -1.19x | ₩-3.52 Billion | ₩-4.79 Billion | ₩2.96 Billion | ▼ -1649.6% |
| 2016 | -0.07x | ₩-176.12 Million | ₩-3.45 Billion | ₩2.59 Billion | — |